Evolution of the Average Target: Temenos Group

Evolution of the Target Price: Temenos Group

Changes in Analyst Recommendations: Temenos Group

cf37ed3a7782d2e0e9e4d0840.mF6uugQMyBz-EY3Wza5EcR2BUtlmIKhbadcKH9tLNFk.4Dvi2GVNiXWdJMe7oesQPivUNbYrdc4rJ499aeghayrvZ8DJZTr-SIwm3A~ddf89a26a06f11c28172fe2c00b97a64
08/06 Berenberg Says Temenos Positioned for 'Strong' Operational Delivery Amid 'Exaggerated' Generative AI Fears MT
19/05 AlphaValue/Baader Europe Upgrades Temenos to Add, Lifts PT MT
13/05 Swiss stocks - Factors to watch on May 13 RE
29/04 Swiss stocks - Factors to watch on April 29 RE
24/04 Temenos Estimates, Price Target Increased as Berenberg Notes Strong Q1 Results MT
22/04 Temenos: The devil is in the details Alphavalue
14/04 Citi Upgrades Temenos to Buy Rating, Boosts PT MT
30/03 AlphaValue/Baader Europe Upgrades Temenos to Add, Lifts PT MT
20/03 Berenberg Begins Temenos Coverage at Buy Amid Banking Software Market Leadership, Subscription Pivot MT
17/03 Will the law remain on the side of Software for much longer? Alphavalue
05/03 Temenos: Confidence restored: heading for deliverance Alphavalue
05/03 Temenos: Temenos: rewriting the future after strong 2025 Alphavalue
25/02 Temenos: SaaS transition complete, US execution remains the challenge Alphavalue
20/02 Oddo BHF Upgrades Temenos to Neutral Rating, Boosts PT MT
19/02 Morningstar Upgrades Temenos to Buy MT
17/02 Temenos: EPS cut (2025: +0.5%, 2026: -22.0%) Alphavalue
03/12 Swiss stocks - Factors to watch on December 3 RE
03/11 Swiss stocks - Factors to watch on November 3 RE
29/25/29 Swiss stocks - Factors to watch on October 29 RE
28/25/28 Temenos expects stable sales environment for rest of year - interim CEO on call RE
13/25/13 Morningstar Begins Temenos Coverage at Hold MT
22/25/22 Baader Helvea Reduces Temenos' Price Target on 'Weaker-than-expected' Start to 2025 MT
21/25/21 HSBC Lifts Temenos's Price Target on Strong Q4 2024 Performance MT
14/25/14 Swiss Equities Close Little Changed; Temenos Shines on Q4 2024 Beat MT
14/25/14 Baader Helvea Keeps Temenos at Reduce Despite Q4 Revenue Beat; Target Price Up MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+50.45%
+61.83%
-3.95%
+3.05%
+24.08%
+0.98%
+53.83%
+18.09%
+36.28%
Average +27.18%
Weighted average by Cap. +45.59%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
80.18USD
Average target price
104.66USD
Spread / Average Target
+30.54%
High Price Target
137.99USD
Spread / Highest target
+72.10%
Low Price Target
72.68USD
Spread / Lowest Target
-9.35%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

AlphaValue/Baader Europe
alphavalue Maximilien Pascaud
Citigroup
ODDO BHF
Morningstar
Research Capital
Stifel Nicolaus
Kepler Capital Markets
Morgan Stanley
HSBC
Deutsche Bank Securities
Goldman Sachs
Exane BNP
Auriga
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
80.18USD
Average target price
104.66USD
Spread / Average Target
+30.54%

Quarterly revenue - Rate of surprise